NCT06071910 (ERICA-ARREST) is a NA clinical trial of ER-REBOA catheter in Out-Of-Hospital Cardiac Arrest, sponsored by Queen Mary University of London.

Who is sponsoring NCT06071910?

NCT06071910 is sponsored by Queen Mary University of London.

What drugs are being tested in NCT06071910?

Interventions in NCT06071910: ER-REBOA catheter.

What condition does NCT06071910 study?

NCT06071910 studies Out-Of-Hospital Cardiac Arrest, Cardiac Arrest, Cardiac Arrhythmia, Ventricular Fibrillation, Ventricular Arrythmia, Pulseless Electrical Activity.

Is NCT06071910 still recruiting?

NCT06071910 is currently recruiting now. Last updated 2 March 2026.

Last reviewed 2026-03-02 · How we verify

NCT06071910: ERICA-ARREST

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Emergency Resuscitative Endovascular Balloon Occlusion of the Aorta in Out of Hospital Cardiac Arrest

Recruiting now NA Last updated 2 March 2026

What this trial tests

NA trial testing ER-REBOA catheter in Out-Of-Hospital Cardiac Arrest in 40 participants. Currently enrolling.

Timeline

4 June 2024

Primary endpoint
1 June 2026

31 December 2026

Quick facts

Lead sponsor	Queen Mary University of London
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	na
Design	sequential
Masking	none
Primary purpose	treatment
Enrollment	40
Start date	4 June 2024
Primary completion	1 June 2026
Estimated completion	31 December 2026
Sites	1 location across United Kingdom

Drugs / interventions tested

ER-REBOA catheter

Conditions studied

Out-Of-Hospital Cardiac Arrest — all drugs for Out-Of-Hospital Cardiac Arrest →
Cardiac Arrest — all drugs for Cardiac Arrest →
Cardiac Arrhythmia — all drugs for Cardiac Arrhythmia →
Ventricular Fibrillation — all drugs for Ventricular Fibrillation →

Sponsor

Queen Mary University of London

Who can join

Adults 18 to 80, any sex, with Out-Of-Hospital Cardiac Arrest or Cardiac Arrest. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will assess the feasibility of performing pre-hospital resuscitative endovascular balloon occlusion of the aorta (REBOA) as an adjunct to conventional Advanced Life Support (ALS) in patients suffering from non-traumatic out of hospital cardiac arrest (OHCA). As well as providing valuable insights into the technical feasibility of performing this procedure as part of a resuscitation attempt, the study will also document the beneficial physiological effects of REBOA in this group of patients.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Implementation of advanced vascular access, physiological monitoring and goal-directed resuscitation during OHCA in a helicopter emergency medical service.
Aziz S, Lachowycz K, Major R, Rees P, et al · · 2025 · cited 6× · PMID 38610111 · DOI 10.1177/11297298241242157
A protocol for the ERICA-ARREST feasibility study of Emergency Resuscitative Endovascular Balloon occlusion of the Aorta in Out-of-Hospital Cardiac Arrest.
Aziz S, Barratt J, Wilson-Baig N, Lachowycz K, et al · · 2024 · cited 3× · PMID 38974930 · DOI 10.1016/j.resplu.2024.100688

Verify or expand the search:

Other trials of ER-REBOA catheter

Trials testing the same drug.

NCT03703453 — Resuscitative EndoVascular Aortic Occlusion for Maximal Perfusion · EARLY_PHASE1 · completed

Other recruiting trials for Out-Of-Hospital Cardiac Arrest

Currently open trials in the same condition.

NCT06538155 — Technological and Patient-tailored Innovations for Maximizing Effectiveness of Cardiac Arrest Resuscitation · recruiting
NCT06530433 — Enhanced Community First Responder System Evaluation in Singapore · NA · recruiting
NCT06203847 — The Effect of Prehospital Combination of Epinephrine, Vasopressin, and Steroid in OHCA · NA · recruiting
NCT06306625 — REmote COnditioning in Out-of-Hospital Cardiac Arrest · NA · recruiting
NCT06072092 — Frontal EEG in OHCA Feasibility Study · active not recruiting

Other Queen Mary University of London trials

Trials by the same sponsor.

NCT07246005 — LVT DURATION: Pilot Study of Anticoagulation Duration for Left Ventricular Thrombus · Phase 2 · not yet recruiting
NCT07165678 — CTCA Prior to Invasive Angiography in Post-Bypass Patients (BYPASS CTCA 2) · NA · not yet recruiting
NCT06937372 — Delivery and Implementation of a Randomised Crossover Trial on Thrombosis · NA · not yet recruiting
NCT06600438 — Slow-SPEED UK: A Double-Blind Randomised Feasibility Trial · NA · not yet recruiting
NCT06987045 — Trans and Non-binary Prostate-Specific Antigen Reference Interval Determination Study · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06071910 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Queen Mary University of London
Last refreshed: 2 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06071910.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing